⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2804458 | 0.86 | — | — | |
| SCHEMBL14861338 | 0.85 | — | — | |
| SCHEMBL3792608 | 0.76 | — | — | |
| SCHEMBL5193769 | 0.74 | — | — | |
| SCHEMBL9446214 | 0.74 | KDM4E (0.33) | — | |
| SCHEMBL262653 | 0.72 | CHRM1 (0.31) | — | |
| Acetic Acid SCHEMBL27609064 | 0.71 | ACACB (0.33) | — | |
| SCHEMBL2804997 | 0.71 | — | — | |
| SCHEMBL532589 | 0.70 | — | — | |
| SCHEMBL2680481 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1280929-A2 | VECTORS FOR OCULAR TRANSDUCTION AND USE THEREOF FOR GENETIC THERAPY | Novartis AG (CH) | 2003-02-05 | — | — | EP | disclosed |
| WO-2001083729-A2 | VECTORS FOR OCULAR TRANSDUCTION AND USE THEREOF FOR GENETIC THERAPY | NOVARTIS AG (CH) | 2001-11-08 | — | — | WO | disclosed |
| EP-0973926-A1 | ADENOVIRAL VECTORS WITH MODIFIED TROPISM | Selective Genetics, Inc. (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998040508-A1 | ADENOVIRAL VECTORS WITH MODIFIED TROPISM | SELECTIVE GENETICS, INC. (US) | 1998-09-17 | — | — | WO | disclosed |
| WO-1998039436-A2 | FIBROBLAST GROWTH FACTOR MUTEIN COMPOSITIONS AND METHODS OF USE THEREFOR | EISAI CO., LTD. (JP) | 1998-09-11 | — | — | WO | disclosed |
| EP-0833665-A1 | COMPOSITIONS CONTAINING NUCLEIC ACIDS AND LIGANDS FOR THERAPEUTIC TREATMENT | PRIZM PHARMACEUTICALS, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0776218-A2 | HEPARIN-BINDING GROWTH FACTORS FOR GENE THERAPY AND ANTERIOR EYE DISORDERS | PRIZM PHARMACEUTICALS, INC. (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0754046-A1 | USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE | FREEMAN, William R. (US) | 1997-01-22 | — | — | EP | disclosed |
| WO-1996036362-A1 | COMPOSITIONS CONTAINING NUCLEIC ACIDS AND LIGANDS FOR THERAPEUTIC TREATMENT | PRIZM PHARMACEUTICALS, INC. (US) | 1996-11-21 | — | — | WO | disclosed |
| WO-1995026734-A1 | USE OF PHOSPHONYLMETHOXYALKYL NUCLEOSIDES FOR THE TREATMENT OF RAISED INTRAOCULAR PRESSURE | FREEMAN WILLIAM R (US) | 1995-10-12 | — | — | WO | disclosed |
| WO-1995024928-A2 | HEPARIN-BINDING GROWTH FACTORS FOR GENE THERAPY AND ANTERIOR EYE DISORDERS | PRIZM PHARMACEUTICALS, INC. (US) | 1995-09-21 | — | — | WO | disclosed |